HKD 0.06
(0.0%)
Year | Operating Income | Operating Income Growth |
---|---|---|
2023 | 18.8 Million CNY | -76.09% |
2022 | 13.12 Million CNY | -14.07% |
2021 | 15.27 Million CNY | -33.01% |
2020 | 22.79 Million CNY | 76.94% |
2019 | 12.88 Million CNY | 90.68% |
2018 | 6.75 Million CNY | -21.94% |
2017 | 8.65 Million CNY | -47.01% |
2016 | 16.33 Million CNY | -53.67% |
2015 | 35.26 Million CNY | 61.76% |
2014 | 21.79 Million CNY | 40.54% |
2013 | 15.51 Million CNY | 0.0% |
Year | Operating Income | Operating Income Growth |
---|---|---|
2024 Q1 | -4.54 Million CNY | -504.73% |
2024 Q2 | -4.54 Million CNY | 0.0% |
2023 Q3 | 7.8 Million CNY | 1593.49% |
2023 Q2 | 461 Thousand CNY | 219.43% |
2023 FY | 3.13 Million CNY | -76.09% |
2023 Q1 | -386 Thousand CNY | -103.71% |
2023 Q4 | -751 Thousand CNY | -109.62% |
2022 Q2 | 1.53 Million CNY | 131.38% |
2022 FY | 13.12 Million CNY | -14.07% |
2022 Q3 | 3.55 Million CNY | 132.42% |
2022 Q1 | -4.87 Million CNY | -153.9% |
2022 Q4 | 10.41 Million CNY | 192.8% |
2021 Q1 | -3.67 Million CNY | -126.66% |
2021 FY | 15.27 Million CNY | -33.01% |
2021 Q4 | 9.04 Million CNY | 93.7% |
2021 Q3 | 4.66 Million CNY | 160.26% |
2021 Q2 | 1.79 Million CNY | 148.86% |
2020 Q1 | -4.56 Million CNY | -195.1% |
2020 Q3 | -453 Thousand CNY | -104.56% |
2020 Q2 | 9.93 Million CNY | 317.64% |
2020 FY | 22.79 Million CNY | 76.94% |
2020 Q4 | 13.77 Million CNY | 3140.84% |
2019 Q3 | 6.98 Million CNY | 292.75% |
2019 Q2 | -3.62 Million CNY | 24.27% |
2019 Q1 | -4.78 Million CNY | -114.11% |
2019 FY | 12.88 Million CNY | 90.68% |
2019 Q4 | 4.79 Million CNY | -31.34% |
2018 FY | 6.75 Million CNY | -21.94% |
2018 Q2 | -3.73 Million CNY | -879.95% |
2018 Q3 | 3.26 Million CNY | 187.31% |
2018 Q1 | -381.5 Thousand CNY | -105.59% |
2018 Q4 | -2.23 Million CNY | -168.5% |
2017 Q3 | 8.91 Million CNY | 375.49% |
2017 Q2 | -3.23 Million CNY | 15.89% |
2017 Q1 | -3.84 Million CNY | -253.17% |
2017 FY | 8.65 Million CNY | -47.01% |
2017 Q4 | 6.82 Million CNY | -23.42% |
2016 FY | 16.33 Million CNY | -53.67% |
2016 Q4 | 2.51 Million CNY | -70.75% |
2016 Q3 | 8.58 Million CNY | 906.86% |
2016 Q1 | 6.3 Million CNY | -55.35% |
2016 Q2 | -1.06 Million CNY | -116.88% |
2015 FY | 35.26 Million CNY | 61.76% |
2015 Q4 | 14.11 Million CNY | 5.98% |
2015 Q2 | 2.61 Million CNY | 0.0% |
2015 Q3 | 13.31 Million CNY | 408.9% |
2014 FY | 21.79 Million CNY | 40.54% |
2013 FY | 15.51 Million CNY | 0.0% |
Name | Operating Income | Operating Income Difference |
---|---|---|
Natural Beauty Bio-Technology Limited | -3.73 Million HKD | 603.157% |
Innovative Pharmaceutical Biotech Limited | -13.43 Million HKD | 240.003% |
China Overseas Nuoxin International Holdings Limited | -2.63 Million HKD | 813.505% |
Prosperous Future Holdings Limited | -30.27 Million HKD | 162.131% |
Huasheng International Holding Limited | 994 Thousand HKD | -1792.153% |
Fourace Industries Group Holdings Limited | 39.7 Million HKD | 52.635% |
Evergreen Products Group Limited | 81.06 Million HKD | 76.798% |
EC Healthcare | 186.03 Million HKD | 89.89% |
Ming Fai International Holdings Limited | 144.06 Million HKD | 86.945% |
Blue Moon Group Holdings Limited | 130.43 Million HKD | 85.581% |
SuperRobotics Holdings Limited | -7.88 Million HKD | 338.68% |
Takbo Group Holdings Limited | 9.68 Million HKD | -94.157% |
Hyfusin Group Holdings Limited | 138.63 Million HKD | 86.433% |